CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Newcastle Australia
Newcastle, AustraliaPublications in collaboration with researchers from University of Newcastle Australia (14)
2024
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
2023
-
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Frontiers in Neurology, Vol. 14
2022
2021
-
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Computer Methods and Programs in Biomedicine, Vol. 208
2019
-
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243
2018
-
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 642-652
2017
-
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 88, Núm. 3, pp. 196-203
-
Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response
Brain, Vol. 140, Núm. 9, pp. 2426-2443
2016
-
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 87, Núm. 12, pp. 1343-1349
2015
-
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis
JAMA Neurology, Vol. 72, Núm. 4, pp. 405-413
-
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
PLoS ONE, Vol. 10, Núm. 6
-
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 1
-
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
Annals of Neurology, Vol. 77, Núm. 3, pp. 425-435
2012
-
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 974-982